PEP-Therapy
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
2,528Activities
Technologies
Entity types
Location
111 Av. de France, 75013 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 15
SIREN
799395215Engaged corporates
5
4 2Added in Motherbase
6 years, 1 month ago
deeptech Value proposition
Innovative peptides as targeted therapies for oncology
PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology.
PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile.
PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors.
PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.
cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancerOriginal language
Innovative peptides as targeted therapies for oncology
PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology.
PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile.
PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors.
PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.
PEP-Therapy, Innovative peptides as targeted therapies for oncology
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology.
https://pep-therapy.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Elsevier Publishing, IT Services and IT Consulting | Elsevier Publishing, IT Services and IT Consulting | Other 30 Sep 2024 | | |
 | LUTECH | Other 15 Mar 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 4 Sep 2024 | | |
 Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 20 Jul 2023 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 27 Apr 2024 | | |